Fig. 4
From: An assessment of prognostic immunity markers in breast cancer
Validation of iRDM subtype and risk survival analysis in three independent test datasets. Survival plots of iRDM subtypes in METABRIC (A) (p < 0.0001, n = 1997), TCGA (C) (p = 0.022, n = 996), TARGETSEQ (E) (p = 0.00021, n = 303) and survival plots of risk groups (high, low, med) in METABRIC (B) (p < 0.0001, n = 1997), TCGA (D) (p = 0.00019, n = 996), TARGETSEQ (E) (p < 0.0001, n = 303) were shown. Subtypes and risk groups are color-coded: Basal-like (Red), HER2E (Hot Pink), Immuno (Yellow), Luminal A (Dark Blue), Luminal B (Sky Blue), Normal-like (Green); low (Green), med (Dark Blue), and high (Red) risks
